135 related articles for article (PubMed ID: 37417635)
21. Infantile fibrosarcoma treated with postoperative vincristine and dactinomycin.
Yoshihara H; Yoshimoto Y; Hosoya Y; Hasegawa D; Kawano T; Sakoda A; Okita H; Manabe A
Pediatr Int; 2017 Mar; 59(3):371-374. PubMed ID: 28317309
[TBL] [Abstract][Full Text] [Related]
22. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
[TBL] [Abstract][Full Text] [Related]
23. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
[TBL] [Abstract][Full Text] [Related]
24. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
[TBL] [Abstract][Full Text] [Related]
25. Infantile fibrosarcoma of thigh--a case report.
Himori K; Hatori M; Watanabe M; Moriya T; Ogose A; Hashimoto H; Kokubun S
Ups J Med Sci; 2005; 110(1):85-93. PubMed ID: 15801689
[TBL] [Abstract][Full Text] [Related]
26. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.
Sheng WQ; Hisaoka M; Okamoto S; Tanaka A; Meis-Kindblom JM; Kindblom LG; Ishida T; Nojima T; Hashimoto H
Am J Clin Pathol; 2001 Mar; 115(3):348-55. PubMed ID: 11242790
[TBL] [Abstract][Full Text] [Related]
27. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.
Knezevich SR; McFadden DE; Tao W; Lim JF; Sorensen PH
Nat Genet; 1998 Feb; 18(2):184-7. PubMed ID: 9462753
[TBL] [Abstract][Full Text] [Related]
28. A novel ETV6-NTRK3 gene fusion in primary renal fibrosarcoma.
Jiang H
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
[TBL] [Abstract][Full Text] [Related]
29. Recurrent Leiomyosarcoma With Malignant Transformation.
Malaviarachchi S; Balawardana J; Senanayake A; Perera R; Liyanage S
Cureus; 2021 Jan; 13(1):e12672. PubMed ID: 33604210
[TBL] [Abstract][Full Text] [Related]
30. Retroperitoneal infantile fibrosarcoma: clinical, molecular, and therapeutic aspects of an unusual tumor.
Ramphal R; Manson D; Viero S; Zielenska M; Gerstle T; Pappo A
Pediatr Hematol Oncol; 2003 Dec; 20(8):635-42. PubMed ID: 14578034
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of ETV6-NTRK3 fusion gene-negative infantile fibrosarcoma with metastatic lesion resistant to VAC chemotherapy.
Moriya K; Abe S; Onuma M; Sato A; Takeyama J; Hosaka M; Sasahara Y; Imaizumi M
Pediatr Int; 2018 Nov; 60(11):1045-1046. PubMed ID: 30536487
[No Abstract] [Full Text] [Related]
32. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, Boston.
Loh ML; Ahn P; Perez-Atayde AR; Gebhardt MC; Shamberger RC; Grier HE
J Pediatr Hematol Oncol; 2002 Dec; 24(9):722-6. PubMed ID: 12468912
[TBL] [Abstract][Full Text] [Related]
33. An infant with ETV6-NTRK3 fusion-positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition.
Vedi A; Holland K; Cross J; Muthusamy B; Behjati S; Hook CE; Murray MJ
Pediatr Blood Cancer; 2020 Oct; 67(10):e28628. PubMed ID: 32748441
[No Abstract] [Full Text] [Related]
34. Distant metastatic spread of molecularly proven infantile fibrosarcoma of the chest in a 2-month-old girl: case report and review of literature.
van Grotel M; Blanco E; Sebire NJ; Slater O; Chowdhury T; Anderson J
J Pediatr Hematol Oncol; 2014 Apr; 36(3):231-3. PubMed ID: 24276045
[TBL] [Abstract][Full Text] [Related]
35. Spindle cell sarcoma with
Fujikawa T; Uemura S; Yoshida M; Hyodo S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Uematsu A; Morita K; Hatakeyama T; Tamura A; Yamamoto N; Komatsu M; Soejima T; Hasegawa D; Kosaka Y
Oncol Lett; 2022 Dec; 24(6):452. PubMed ID: 36380878
[TBL] [Abstract][Full Text] [Related]
36. Advances in the adjuvant treatment of infantile fibrosarcoma.
Ferguson WS
Expert Rev Anticancer Ther; 2003 Apr; 3(2):185-91. PubMed ID: 12722878
[TBL] [Abstract][Full Text] [Related]
37. Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report.
Corral Sánchez MD; Galán Gómez V; Sastre Urgelles A; Plaza López de Sabando D; Rubio Aparicio P; Martínez Martínez L; Alonso Gamarra E; Pozo Kreilinger JJ; Regojo Zapata RM; López Gutiérrez JC; Antolín Alvarado E; Gómez Martín F; Sánchez Torres AM; Marín Manzano E; González Del Valle L; Pérez-Martínez A
Pediatr Hematol Oncol; 2021 Aug; 38(5):504-509. PubMed ID: 33622165
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
Hung YP; Fletcher CDM; Hornick JL
Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
[TBL] [Abstract][Full Text] [Related]
39. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.
Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH
Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307
[TBL] [Abstract][Full Text] [Related]
40. Congenital intestinal fibrosarcoma with rapid recurrence requiring adjuvant chemotherapy.
See WSQ; Cheuk DKL; To KF; Ip PP; Chiang AKS; Ha SY; Chan GCF
Pediatr Int; 2017 Jun; 59(6):733-736. PubMed ID: 28436622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
